围术期医学标准化终点共识:术后肿瘤结局
该研究通过系统综述和多轮Delphi共识,为评估麻醉镇痛技术对肿瘤结局影响的临床试验制定标准化终点。最终确定10个定义明确的终点,其中6个获≥70%专家组认可,包括癌症健康相关生活质量、90天存活且出院天数、肿瘤进展时间、无病生存、癌症特异性生存和总生存。推荐在相关临床试验中纳入这些共识终点以支持基准比较和荟萃分析。
要点
- 推荐在评估麻醉镇痛技术对肿瘤结局影响的临床试验中使用共识终点。
- 6个终点获≥70%专家组认可,包括癌症健康相关生活质量和总生存等。
- 标准化终点有助于试验的基准比较和荟萃分析。
核心结论
- 推荐在评估麻醉-镇痛技术对肿瘤结局因果效应的临床试验中,考虑纳入一个或多个共识衍生的标准化终点。
研究设计与样本
- 系统综述检索肿瘤学、外科及更广泛文献中使用的肿瘤结局指标。
- 多轮Delphi共识过程,最多包括89名临床研究者。
主要发现
- 文献检索识别90项研究,初步列出9个结局指标及其定义。
- Delphi过程中新增2个指标,最终形成10个定义明确的终点。
- Delphi第一、二、三轮回应率分别为88%(n=9)、82%(n=73)和100%(n=10)。
- 6个终点获≥70%专家组认可:癌症健康相关生活质量、90天存活且出院天数、肿瘤进展时间、无病生存、癌症特异性生存、总生存(及5年总生存)。
关键数值与推荐
- 10个定义明确的终点被最终确定。
- 6个终点获≥70%专家组认可。
临床怎么用
- 在评估麻醉-镇痛技术对肿瘤结局影响的临床试验中,应考虑纳入一个或多个共识终点。
- 标准化终点有助于试验的基准比较和荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Standardising Endpoints for Perioperative Medicine group was established to derive an appropriate set of endpoints for use in clinical trials related to anaesthesia and perioperative medicine. Anaesthetic or analgesic technique during cancer surgery with curative intent may influence the risk of recurrence or metastasis. However, given the current equipoise in the existing literature, prospective, randomised, controlled trials are necessary to test this hypothesis. As such, a cancer subgroup was formed to derive endpoints related to research in onco-anaesthesia based on a current evidence base, international consensus and expert guidance. METHODS: We undertook a systematic review to identify measures of oncological outcome used in the oncological, surgical, and wider literature. A multiround Delphi consensus process that included up to 89 clinician-researchers was then used to refine a recommended list of endpoints. RESULTS: We identified 90 studies in a literature search, which were the basis for a preliminary list of nine outcome measures and their definitions. A further two were added during the Delphi process. Response rates for Delphi rounds one, two, and three were 88% (n=9), 82% (n=73), and 100% (n=10), respectively. A final list of 10 defined endpoints was refined and developed, of which six secured approval by ≥70% of the group: cancer health related quality of life, days alive and out of hospital at 90 days, time to tumour progression, disease-free survival, cancer-specific survival, and overall survival (and 5-yr overall survival). CONCLUSION: Standardised endpoints in clinical outcomes studies will support benchmarking and pooling (meta-analysis) of trials. It is therefore recommended that one or more of these consensus-derived endpoints should be considered for inclusion in clinical trials evaluating a causal effect of anaesthesia-analgesia technique on oncological outcomes.
引用
- Buggy DJ, Freeman J, Johnson MZ, et al. Systematic review and consensus definitions for standardised endpoints in perioperative medicine: postoperative cancer outcomes. Br J Anaesth. 2018. PMID: 29935592. doi:10.1016/j.bja.2018.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。